| abstract |
A platelet rich plasma (PRP) composition is provided. In general, these compositions contain higher concentrations of platelets and leukocytes than whole blood. The concentration of platelets and / or leukocytes may be 2 to 8 times the respective concentration in whole blood. In these compositions, the concentration of red blood cells and hemoglobin may be suppressed. In some variations, the composition may be useful for treating damaged connective tissue and / or for delaying or stopping cardiac apoptosis after a heart attack. The PRP composition may be delivered in conjunction with reperfusion therapy. |